Incyte to Present at Upcoming Investor Conference
WILMINGTON, Del.–(BUSINESS WIRE)–
Incyte (Nasdaq:INCY) announced today that it will present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference on Tuesday, December 1, 2020 at 10:30 a.m. EST.
The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 90 days.
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
Catalina Loveman, +1 302 498 6171
Michael Booth, DPhil, +1 302 498 5914
KEYWORDS: Delaware United States North America
INDUSTRY KEYWORDS: Biotechnology General Health Pharmaceutical Health